PCI Biotech Holding ASA - ESG Rating & Company Profile powered by AI
If you work at PCI Biotech Holding ASA and you wish to use your Sustainability rating, please contact us. The webpage contains a zero-cost Sustainability analysis covering PCI Biotech Holding ASA. This webpage contains a questions and answers section for PCI Biotech Holding ASA.
PCI Biotech Holding ASA in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.8; made up of an environmental score of 6.0, social score of 5.3 and governance score of 5.7.
5.8
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 716 | Vaxart Inc | 5.9 | High |
| 716 | Vertex Pharmaceuticals Inc | 5.9 | High |
| 751 | PCI Biotech Holding ASA | 5.8 | High |
| 751 | Apontis Pharma AG | 5.8 | High |
| 751 | BioLine RX Ltd | 5.8 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does PCI Biotech Holding ASA have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose current and historical energy intensity?
Sign up for free to unlockDoes PCI Biotech Holding ASA report the average age of the workforce?
Sign up for free to unlockDoes PCI Biotech Holding ASA reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose its ethnicity pay gap?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose cybersecurity risks?
Sign up for free to unlockDoes PCI Biotech Holding ASA offer flexible work?
Sign up for free to unlockDoes PCI Biotech Holding ASA have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose the number of employees in R&D functions?
Sign up for free to unlockDoes PCI Biotech Holding ASA conduct supply chain audits?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes PCI Biotech Holding ASA conduct 360 degree staff reviews?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose the individual responsible for D&I?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose water use targets?
Sign up for free to unlockDoes PCI Biotech Holding ASA have careers partnerships with academic institutions?
Sign up for free to unlockDid PCI Biotech Holding ASA have a product recall in the last two years?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose incidents of discrimination?
Sign up for free to unlockDoes PCI Biotech Holding ASA allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas PCI Biotech Holding ASA issued a profit warning in the past 24 months?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose parental leave metrics?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose the pay ratio of women to men?
Sign up for free to unlockDoes PCI Biotech Holding ASA support suppliers with sustainability related research and development?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes PCI Biotech Holding ASA reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs PCI Biotech Holding ASA involved in embryonic stem cell research?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose its waste policy?
Sign up for free to unlockDoes PCI Biotech Holding ASA report according to TCFD requirements?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose energy use targets?
Sign up for free to unlockDoes PCI Biotech Holding ASA disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes PCI Biotech Holding ASA have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for PCI Biotech Holding ASA
These potential risks are based on the size, segment and geographies of the company.
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in Phase I clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense. PCI Biotech Holding ASA is based in Oslo, Norway.